µ-Opioid Receptor is Expressed on Cat Epididymal Sperm Cells
World Small Animal Veterinary Association World Congress Proceedings, 2003
G. Aiudi; M. Albrizio; A.C. Guaricci; L. Valentini; M. Cinone1; P. Minoia
Dep. of Animal Production, University of Bari, Bari; 1Dep. of Surgery, Physiopathology and Clinic of Domestic Animals Reproduction, University of Messina


Many physiological and pathological conditions are controlled by the fluctuation of endogenous opioid peptides whose action accomplishes by their link to opioid receptors. The present study was carried out to evaluate the presence of the µ-opioid receptor on cat epididymal sperm cells.

Materials & Methods

Sperm cells collected from epididymis obtained from orchiectomized toms were normal for motility and morphology. Spermatozoa were fixed in 4% (v/v) paraformaldehyde, incubated in PBS-1%BSA and let to react in a 1:2500 dilution of primary rabbit polyclonal antibody against rat 3rd extracellular loop of µ-opioid receptor. The antibody was omitted in control samples. The FITC-conjugated-IgG-secondary antibody diluted 1:200 was added and after incubation, samples were smeared on slides. Duplicate slides were prepared, assembled with mounting medium and observed under a fluorescent microscope (1000x magnification).


µ-opioid receptors were evidenced as a light green stain on the surface of the anterior region of the head, on the neck and on the final segment of the sperm tail. No staining was detected in negative controls incubated with the FITC labeled secondary antibody.


The immunocytofluorescence method is specific and reliable to study distribution and expression of opioid receptors on cats spermatozoa and may be useful to detect abnormal distribution or absence of the µ-opioid receptor on spermatozoa.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

G. Aiudi
Dep. of Animal Production
University of Bari, Bari

MAIN : Reproduction : Opioid Receptor:Sperm Cells
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.


777 W. Covell Blvd., Davis, CA 95616



  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357